| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
|
Kivitz, Alan J.
|
|
2018
|
48 |
3 |
p. 406-415
|
article
|
| 2 |
Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review
|
Gwinnutt, James M.
|
|
2018
|
48 |
3 |
p. 384-398
|
article
|
| 3 |
Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
|
Cooksey, Roxanne
|
|
2018
|
48 |
3 |
p. 367-373
|
article
|
| 4 |
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
|
Cappelli, Laura C.
|
|
2018
|
48 |
3 |
p. 553-557
|
article
|
| 5 |
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach
|
Marrani, Edoardo
|
|
2018
|
48 |
3 |
p. 495-503
|
article
|
| 6 |
Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review
|
Paxton, Dolcie
|
|
2018
|
48 |
3 |
p. 482-494
|
article
|
| 7 |
Editorial Board
|
|
|
2018
|
48 |
3 |
p. ii
|
article
|
| 8 |
Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study
|
Yue, Jiang
|
|
2018
|
48 |
3 |
p. 374-383
|
article
|
| 9 |
Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
|
Bannuru, Raveendhara R.
|
|
2018
|
48 |
3 |
p. 416-429
|
article
|
| 10 |
Functional impairment measurement in psoriatic arthritis: Importance and challenges
|
Mease, Philip
|
|
2018
|
48 |
3 |
p. 436-448
|
article
|
| 11 |
High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?
|
Arias-Guillén, Miguel
|
|
2018
|
48 |
3 |
p. 538-546
|
article
|
| 12 |
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes
|
Ferri, Clodoveo
|
|
2018
|
48 |
3 |
p. 475-481
|
article
|
| 13 |
Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
|
Fanouriakis, Antonis
|
|
2018
|
48 |
3 |
p. 467-474
|
article
|
| 14 |
Medications received by patients with juvenile dermatomyositis
|
Kishi, Takayuki
|
|
2018
|
48 |
3 |
p. 513-522
|
article
|
| 15 |
No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study
|
Kim, Seoyoung C.
|
|
2018
|
48 |
3 |
p. 399-405
|
article
|
| 16 |
Patterns of peripheral joint involvement in psoriatic arthritis—Symmetric, ray and/or row?
|
Chandran, Vinod
|
|
2018
|
48 |
3 |
p. 430-435
|
article
|
| 17 |
Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus
|
Kwon, Oh Chan
|
|
2018
|
48 |
3 |
p. 462-466
|
article
|
| 18 |
Smoking as a risk factor for giant cell arteritis: A systematic review and meta-analysis
|
Brennan, David N.
|
|
2018
|
48 |
3 |
p. 529-537
|
article
|
| 19 |
Statin use and mortality in gout: A general population-based cohort study
|
Keller, Sarah F.
|
|
2018
|
48 |
3 |
p. 449-455
|
article
|
| 20 |
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis
|
Schiffenbauer, Adam
|
|
2018
|
48 |
3 |
p. 504-512
|
article
|
| 21 |
The nomenclature of the basic disease elements of gout: A content analysis of contemporary medical journals
|
Bursill, David
|
|
2018
|
48 |
3 |
p. 456-461
|
article
|
| 22 |
Therapeutic tolerance in autoimmune disease
|
Rayner, Fiona
|
|
2018
|
48 |
3 |
p. 558-562
|
article
|
| 23 |
The use of routinely collected patient-reported outcome measures in rheumatoid arthritis
|
Hiligsmann, Mickaël
|
|
2018
|
48 |
3 |
p. 357-366
|
article
|
| 24 |
Trends of Informed Consent forms for industry-sponsored clinical trials in rheumatology over a 17-year period: Readability, and assessment of patients’ health literacy and perceptions
|
de la Mora-Molina, Hector
|
|
2018
|
48 |
3 |
p. 547-552
|
article
|
| 25 |
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial
|
Conway, Richard
|
|
2018
|
48 |
3 |
p. 523-528
|
article
|
Journal description